Pharmaceutical
Health
Therapy

Corcept Therapeutics

$10.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (0.73%) Today
-$0.09 (-0.82%) As of 4:49 PM EDT after-hours

Why Robinhood?

You can buy or sell CORT and other stocks, options, ETFs, and crypto commission-free!

About CORT

Corcept Therapeutics Incorporated Common Stock, also called Corcept Therapeutics, is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Read More Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.

Employees
166
Headquarters
Menlo Park, California
Founded
1998
Market Cap
1.26B
Price-Earnings Ratio
18.13
Dividend Yield
0.00
Average Volume
462.58K
High Today
$11.08
Low Today
$10.83
Open Price
$10.88
Volume
681.98K
52 Week High
$19.48
52 Week Low
$9.14

Collections

Pharmaceutical
Health
Therapy
Technology

CORT Earnings

$0.16
$0.19
$0.21
$0.24
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.